XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 898,928 $ 481,538
Adjustments to reconcile net income to cash provided by operating activities:    
Depreciation, amortization and accretion 299,079 218,303
Share-based compensation 21,987 23,209
Deferred income taxes (85,343) (46,053)
Gain on sales of businesses, net (1,115) (329)
Other, net 3,238 393
Changes in operating assets and liabilities:    
Accounts receivable, trade (68,823) (385,046)
Inventories (434,375) (262,665)
Government grants receivable (59,181) (429,744)
Other assets (183,127) (126,073)
Income tax receivable and payable 35,708 (16,809)
Accounts payable and accrued expenses (8,953) 121,382
Deferred revenue (13,159) 472,934
Other liabilities 2,139 (9,889)
Net cash provided by operating activities 407,003 41,151
Cash flows from investing activities:    
Purchases of property, plant and equipment (1,212,537) (1,039,863)
Purchases of marketable securities and restricted marketable securities (2,014,764) (3,220,467)
Proceeds from sales and maturities of marketable securities 1,897,997 3,996,439
Acquisitions, net of cash acquired 0 (35,739)
Other investing activities (12,617) 0
Net cash used in investing activities (1,341,921) (299,630)
Cash flows from financing activities:    
Proceeds from borrowings under debt arrangements, net of issuance costs 227,654 307,214
Repayments of Debt (205,821) 0
Payments of tax withholdings for restricted shares (20,144) (31,100)
Contingent consideration payment and other financing activities (7,568) 0
Net cash (used in) provided by financing activities (5,879) 276,114
Effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents (2,805) (855)
Net (decrease) increase in cash, cash equivalents, restricted cash, and restricted cash equivalents (943,602) 16,780
Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of the period 1,965,069 1,493,462
Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of the period 1,021,467 1,510,242
Supplemental disclosure of noncash investing and financing activities:    
Property, plant and equipment acquisitions funded by liabilities 264,480 185,064
Proceeds to be received from asset-based government grants 159,490 152,458
Acquisitions funded by contingent consideration $ 11,000 $ 18,500